Can you provide the last earnings date for ORCHESTRA BIOMED HOLDINGS IN?
ORCHESTRA BIOMED HOLDINGS IN (OBIO) last reported earnings on 11/10/2025.
ORCHESTRA BIOMED HOLDINGS IN (OBIO) Earnings History & Surprises
NASDAQ:OBIO • US68572M1062
Current stock price
4.49 USD
+0.29 (+6.9%)
Last:
OBIO Earnings overview
Past quarterly earnings results for ORCHESTRA BIOMED HOLDINGS IN (OBIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 1, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.39
- Revenue Estimate
- 943.204K
Last Reported
Most Recent- Release Date
- Nov 10, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.40
- EPS Surprise
- 9.82%
- Revenue Surprise
- 11.42%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.40 | -0.44 | 9.82% | 2.44% | 861K | 772.752K | 11.42% | -12.77% |
| Q2 2025 | -0.50 | -0.51 | 2.68% | -11.11% | 836K | 709.512K | 17.83% | 7.46% |
| Q1 2025 | -0.49 | -0.49 | 0.13% | -28.95% | 868K | 537.03K | 61.63% | 40.00% |
| Q4 2024 | -0.42 | -0.44 | 3.57% | -13.51% | 253K | 857.993K | -70.51% | -3.44% |
| Q3 2024 | -0.41 | -0.44 | 6.52% | -7.89% | 987K | 725.73K | 36.00% | 135.56% |
| Q2 2024 | -0.45 | -0.40 | -12.33% | -28.57% | 778K | 870.57K | -10.63% | -14.97% |
| Q1 2024 | -0.38 | -0.41 | 6.39% | 5.00% | 620K | 955.403K | -35.11% | -46.74% |
| Q4 2023 | -0.37 | -0.38 | 3.65% | 78.79% | 262K | 1.014M | -74.16% | -76.18% |
| Q3 2023 | -0.38 | -0.40 | 4.47% | - | 419K | 912.9K | -54.10% | -63.88% |
| Q2 2023 | -0.35 | -0.42 | 17.32% | - | 915K | 720.12K | 27.06% | 128.75% |
| Q1 2023 | -0.40 | -0.29 | -37.60% | - | 1.164M | 693.6K | 67.82% | 33.79% |
| Q4 2022 | -1.74 | - | - | 1.1M | 1.204M | -8.64% | 144.90% | |
| Q3 2022 | - | - | 1.16M | - | -12.78% | |||
| Q2 2022 | - | - | 400K | - | 140.82% | |||
| Q1 2022 | - | - | 870K | - | -34.09% | |||
| Q4 2021 | - | - | -2.45M | - | - | |||
| Q3 2021 | - | - | 1.33M | - | - | |||
| Q2 2021 | - | - | -980K | - | - | |||
| Q1 2021 | - | - | 1.32M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
4.05%
Max EPS beat (4)
9.82%
Min EPS beat (4)
0.13%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
5.09%
Max Revenue beat (4)
61.63%
Min Revenue beat (4)
-70.51%
Analysis
In the last 4 quarters, OBIO has consistently beaten EPS estimates in all releases
OBIO has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, OBIO has beaten the EPS estimates by 4.0% on average.
In the last 4 quarters, OBIO has beaten the revenue estimates by 5.1% on average.
Related analysis
ORCHESTRA BIOMED HOLDINGS IN / OBIO Earnings FAQ
Can you provide information on whether ORCHESTRA BIOMED HOLDINGS IN beat earnings estimates in the last quarter?
ORCHESTRA BIOMED HOLDINGS IN (OBIO) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often ORCHESTRA BIOMED HOLDINGS IN beats earnings estimates?
In the last 4 quarters, ORCHESTRA BIOMED HOLDINGS IN (OBIO) has beaten EPS estimates in 4 out of 4 releases.